Wells Fargo & Company Novo Cure LTD Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Novo Cure LTD stock. As of the latest transaction made, Wells Fargo & Company holds 36,886 shares of NVCR stock, worth $653,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,886

Previous 225,506 83.64%

Holding current value

$653,988

Previous $3.86 Million 85.09%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.61 - $23.34 $2.94 Million - $4.4 Million	-188,620 Reduced 83.64%	36,886 $576,000
Q2 2024 Aug 13, 2024	BUY	$11.83 - $24.05 $2.34 Million - $4.75 Million	197,614 Added 708.5%	225,506 $3.86 Million
Q1 2024 May 10, 2024	BUY	$12.42 - $17.29 $137,166 - $190,950	11,044 Added 65.55%	27,892 $435,000
Q4 2023 Feb 09, 2024	SELL	$11.13 - $15.78 $57,608 - $81,677	-5,176 Reduced 23.5%	16,848 $251,000
Q3 2023 Nov 13, 2023	SELL	$16.15 - $42.35 $44,800 - $117,478	-2,774 Reduced 11.19%	22,024 $355,000
Q2 2023 Aug 15, 2023	SELL	$40.29 - $82.51 $253,947 - $520,060	-6,303 Reduced 20.27%	24,798 $1.03 Million
Q1 2023 May 12, 2023	SELL	$56.44 - $118.81 $1.49 Million - $3.14 Million	-26,449 Reduced 45.96%	31,101 $1.87 Million
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $73,960 - $98,687	-1,156 Reduced 1.97%	57,550 $4.22 Million
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $94,302 - $124,233	-1,387 Reduced 2.31%	58,706 $4.46 Million
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $214,627 - $340,900	-3,792 Reduced 5.94%	60,093 $4.18 Million
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $403,005 - $566,284	6,700 Added 11.72%	63,885 $5.29 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $1.91 Million - $3.1 Million	-25,375 Reduced 30.74%	57,185 $4.29 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $58.6 Million - $98.1 Million	-504,227 Reduced 85.93%	82,560 $9.59 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $53.3 Million - $92.2 Million	-408,854 Reduced 41.06%	586,787 $130 Million
Q1 2021 May 13, 2021	SELL	$124.11 - $190.17 $18.1 Million - $27.7 Million	-145,640 Reduced 12.76%	995,641 $132 Million
Q4 2020 Feb 09, 2021	BUY	$112.16 - $174.14 $6.14 Million - $9.54 Million	54,756 Added 5.04%	1,141,281 $197 Million
Q3 2020 Nov 05, 2020	SELL	$58.05 - $111.31 $15.7 Million - $30.1 Million	-270,612 Reduced 19.94%	1,086,525 $121 Million
Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $10.8 Million - $14 Million	188,413 Added 16.12%	1,357,137 $80.5 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $66.7 Million - $112 Million	1,168,724 New	1,168,724 $78.7 Million

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Novo Cure LTD Transaction History